ORCHID: An Online Intervention for Persons With HIV (Miami)
Launched by UNIVERSITY OF MIAMI · Jun 29, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ORCHID trial is designed to help women living with HIV improve their mental health and stay engaged in their care. This study is focusing on providing an online program that teaches valuable skills to cope with the challenges of living with HIV, especially for those who may be at risk of dropping out of their treatment. The aim is to support women who have faced issues like cervical or anal dysplasia, HPV positivity, or mental health challenges like depression or anxiety.
To be eligible for this trial, participants must identify as women, be receiving HIV care at the University of Miami, and have a recent history of health concerns related to HPV or mental health. Participants can be pregnant or at any stage of life. The program is currently looking for women aged 18 and older who are comfortable reading and writing in English. Those who join can expect to participate in an online intervention that offers tools to strengthen their mental health and resilience. This trial offers a supportive space for women to learn and connect while managing their health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Cis-gender women,
- • 2. Receiving human immunodeficiency virus (HIV) care at the University of Miami Women's HIV Service,
- 3. Recent history (12-month) of cervical or anal dysplasia or human papilloma virus (HPV) positivity; AND a recent (12-month) history of one or more of the following:
- • i) drug use (alcohol, tobacco products, marijuana, illicit drugs) or ii) depression or iii) psychiatric condition (anxiety, post-traumatic stress disorder (PTSD)) or iv) unsuppressed HIV viral load d. All life stages - pregnant, non-pregnant, pre/post-menopausal
- Exclusion Criteria:
- • 1. Under 18
- • 2. Not able to read/write English at the 6th grade level
- • 3. Cognitively impaired adults (as documented in medical records)
- • 4. Debilitating psychiatric condition (e.g. schizophrenia/bi-polar/psychotic disorders)
- • 5. Prisoners
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Miami, Florida, United States
Miami, Florida, United States
Patients applied
Trial Officials
Lunthita M Duthely, Ed.D.
Principal Investigator
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported